[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2577 Introduced in House (IH)]







108th CONGRESS
  1st Session
                                H. R. 2577

  To require the Comptroller General to conduct a study and submit to 
     Congress a report on price controls of foreign governments on 
                            pharmaceuticals.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 24, 2003

    Mr. Burgess (for himself and Mr. Bishop of Utah) introduced the 
   following bill; which was referred to the Committee on Energy and 
  Commerce, and in addition to the Committee on Ways and Means, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL


 
  To require the Comptroller General to conduct a study and submit to 
     Congress a report on price controls of foreign governments on 
                            pharmaceuticals.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. STUDY AND REPORT ON FOREIGN PRICE CONTROLS ON 
              PHARMACEUTICALS.

    (a) Study.--The Comptroller General shall conduct a study on--
            (1) the impact of price controls of foreign governments on 
        pharmaceuticals, including the impact of such price controls on 
        full market access for United States pharmaceuticals and on 
        increased prices for pharmaceuticals generally for United 
        States consumers; and
            (2) the extent to which negotiations conducted by the 
        United States Trade Representative under the Bipartisan Trade 
        Promotion Authority Act of 2002 (title XXI of division B of the 
        Trade Act of 2002) facilitate the elimination of such price 
        controls of foreign governments on pharmaceuticals.
    (b) Report.--Not later than 1 year after the date of the enactment 
of this Act, and every 5 years thereafter, the Comptroller General 
shall prepare and submit to Congress a report that contains the results 
of the study conducted under subsection (a) for the preceding 1- or 5-
year period (as the case may be).
                                 <all>